224 related articles for article (PubMed ID: 38009209)
21. Ultrasound stratification of the FDG-avid thyroid nodule.
Beech P; Lavender I; Jong I; Soo G; Ramdave S; Chong A; Nandurkar D
Clin Radiol; 2016 Feb; 71(2):164-9. PubMed ID: 26683088
[TBL] [Abstract][Full Text] [Related]
22. Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group.
Sager S; Vatankulu B; Erdogan E; Mut S; Teksoz S; Ozturk T; Sonmezoglu K; Kanmaz B
Endocrine; 2015 Sep; 50(1):138-45. PubMed ID: 25795290
[TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography.
D'Souza MM; Marwaha RK; Sharma R; Jaimini A; Thomas S; Singh D; Jain M; Bhalla PJ; Tripathi M; Tiwari A; Mishra A; Mondal A; Tripathi RP
Ann Nucl Med; 2010 Jun; 24(5):345-55. PubMed ID: 20373060
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
[TBL] [Abstract][Full Text] [Related]
25. Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?
Muñoz Pérez N; Villar del Moral JM; Muros Fuentes MA; López de la Torre M; Arcelus Martínez JI; Becerra Massare P; Esteva Martínez D; Cañadas Garre M; Coll Del Rey E; Bueno Laraño P; Ferrón Orihuela JA
Langenbecks Arch Surg; 2013 Jun; 398(5):709-16. PubMed ID: 23624819
[TBL] [Abstract][Full Text] [Related]
26. [Preoperative evaluation of cytologically indeterminate thyroid nodules with 18F-FDG PET].
Sebastianes FM; Cerci JJ; Soares Júnior J; Zanoni PH; Tomimori EK; Camargo RY; Meneghetti JC; Pereira MA
Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1176-83. PubMed ID: 19082307
[TBL] [Abstract][Full Text] [Related]
27. Risk-stratification of thyroid nodules examined by
Bakkegaard P; Londero SC; Bonnema SJ; Nielsen VE; Jespersen ML; Swan KZ
Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):4979-4985. PubMed ID: 33713190
[TBL] [Abstract][Full Text] [Related]
28. The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature.
Vriens D; de Wilt JH; van der Wilt GJ; Netea-Maier RT; Oyen WJ; de Geus-Oei LF
Cancer; 2011 Oct; 117(20):4582-94. PubMed ID: 21432844
[TBL] [Abstract][Full Text] [Related]
29. Incidentally detected 18 F-FDG PET-CT-avid thyroid nodules in patients with advanced malignancy: long-term oncological outcomes from a single-centre retrospective cohort.
Owens C; Fitzhugh A; Harrington K; Paleri V; Sharma B; Shur J; Ap Dafydd D
Nucl Med Commun; 2023 Sep; 44(9):810-815. PubMed ID: 37272278
[TBL] [Abstract][Full Text] [Related]
30. Radiomics analysis improves
Giovanella L; Milan L; Piccardo A; Bottoni G; Cuzzocrea M; Paone G; Ceriani L
Endocrine; 2022 Jan; 75(1):202-210. PubMed ID: 34468949
[TBL] [Abstract][Full Text] [Related]
31. Role of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Evaluation of Cytologically Indeterminate Thyroid Nodules.
Buyukdereli G; Aktar Y; Kara E; Uguz A; Sonmez H
Iran J Radiol; 2016 Jan; 13(1):e21186. PubMed ID: 27110335
[TBL] [Abstract][Full Text] [Related]
32. Fluorine-18-fluorodeoxyglucose positron emission tomography in thyroid nodules with indeterminate cytology: a prospective study.
Rosario PW; Rocha TG; Calsolari MR
Nucl Med Commun; 2019 Feb; 40(2):185-187. PubMed ID: 30444748
[TBL] [Abstract][Full Text] [Related]
33. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
[TBL] [Abstract][Full Text] [Related]
34. Preoperative evaluation of thyroid nodules with 18FDG-PET/CT.
Mitchell JC; Grant F; Evenson AR; Parker JA; Hasselgren PO; Parangi S
Surgery; 2005 Dec; 138(6):1166-74; discussion 1174-5. PubMed ID: 16360405
[TBL] [Abstract][Full Text] [Related]
35. Role of
Piccardo A; Trimboli P; Puntoni M; Foppiani L; Treglia G; Naseri M; Bottoni GL; Massollo M; Sola S; Ferrarazzo G; Bruzzone M; Catrambone U; Arlandini A; Paone G; Ceriani L; Cabria M; Giovanella L
Thyroid; 2019 Apr; 29(4):549-556. PubMed ID: 30864903
[TBL] [Abstract][Full Text] [Related]
36. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
[TBL] [Abstract][Full Text] [Related]
37. PET/CT and prediction of thyroid cancer in patients with follicular neoplasm or atypia.
Nguyen TT; Lange NGE; Nielsen AL; Thomassen A; Døssing H; Godballe C; Rohde M
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2109-2117. PubMed ID: 29909471
[TBL] [Abstract][Full Text] [Related]
38. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
Kim TH; Ji YB; Song CM; Kim JY; Choi YY; Park JS; Tae K
World J Surg Oncol; 2015 Jul; 13():217. PubMed ID: 26179774
[TBL] [Abstract][Full Text] [Related]
39. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
[TBL] [Abstract][Full Text] [Related]
40. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
